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Abstract 
Dithiobis(succinimidyl propionate) (DTSP) self-assembled monolayer (SAM) functionalized gold microelectrode array has 
been used for covalent immobilization of monoclonal cortisol antibody (C-Mab). Binding interactions of cortisol to EA/C-
Mab/DTSP/Au electrode was tested using impedimetric technique.  This Bio-electrode was used to estimate the concentration of 
cortisol in samples of saliva and Interstitial Fluid (ISF). Sensors were exposed to solutions with different cortisol concentration 
and label-free electrochemical impedance (EIS) technique was used to make cortisol measurements. EIS results (change in 
charge transfer resistance, Rct) confirmed that EA/C-Mab/DTSP/Au based biosensor can accurately detect cortisol in the range of
1 pM to 1 μM has exhibit detection limit of 1 pM. In-vitro measurement of cortisol levels in saliva and ISF shows good 
correlation with the values obtained with commercial ELISA experiments 
_______________________________________________________________________________________________________
Keywords: Cortisol; Self-assembled monolayer; Electrochemical impedance; Immunosensor; Dithiobis(succinimidyl 
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1. Introduction 
Association of several human diseases (cancer, drug addiction, heart disease) to regular exposure to 
psychosocial stress has led to growing interest in finding new sensors capable of sensitive and specific detection of 
stress.  Cortisol, a stress biomarker, is a steroid hormone which under normal physiological limit level is important 
for the regulation of blood pressure, glucose levels, and carbohydrate metabolism, however under elevated level 
causes numerous diseases [1-3].  In addition, while excess cortisol levels contribute to the development of Cushing’s 
disease with the symptoms of obesity, fatigue and bone fragility, decreased cortisol levels lead to Addison’s disease 
which is manifested by weight loss, fatigue, and darkening of skin folds and scars [1,3].  Hence, a sensor capable of 
measuring cortisol is required to monitor the stress level. Cortisol in blood primarily exists in a bound state with 
corticosteroid-binding globulin (CBG).  It has been reported that while nearly 90% of cortisol is bound, about 10% 
of it exists in a free biologically active form [4] and can also be found in bodily fluids like saliva, urine and 
interstitial fluids (ISF).   
Recently it has been shown that, there is a good correlation in the amount of free cortisol present in the 
saliva and the total cortisol present in the blood (5), however, free cortisol levels in saliva is up to 100-fold lower 
than in serum [6,7].  Thus measurement of free cortisol requires reliable and accurate collection of any body fluid, 
e.g., blood, saliva, or urine.  Blood collection, however, requires trained medical personnel and the trauma of 
venipuncture that results in much reduced patient participation.  Hence, researchers have been exploring minimally 
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invasive techniques and these efforts have resulted in completely non-invasive sampling: (a) saliva or (b) urine for 
the free cortisol concentration estimation.  The need for the patient to collect samples at odd hours, however, adds 
to additional stress, thereby adding a bias constituent to the results.  Collection of ISF is a technique, which while 
minimally invasive, does not require the patient’s compliance as a simple ISF harvesting device, attached to the 
patients can be utilized to harvest ISF continuously.  These harvesting devices can harvest ISF continually over 2-3 
days without any additional compliance from the patient [8, 9].  The use of ISF collection approach necessitates 
development of a wearable technique that can accurately measure cortisol in ISF.   
Current techniques used for estimation of free cortisol, e.g. High Performance Liquid Chromatography; 
fluorometric assay; and reverse phase chromatography give precise results however; require long analysis time, are 
expensive, and cannot be implemented at point of care.  Alternate techniques of cortisol detection including 
radioimmunoassay, flow immunoassay and enzyme-linked immunosorbent assay [1, 4, 10-12] are though reliable 
and accurate, have problems of laborious, time-consuming, large sample volume requirement and cumbersome.  
Recently, various biosensors have been reported for cortisol estimation [1, 3, 13-15].  However, all of these involve 
complicated system, tedious fabrication, and indirect cortisol estimation.  Biosensor development using 
combination of self-assembled monolayers (SAM) which provide molecular level interface for binding of 
biomolecule and electrochemical techniques that known for their enhance sensitivity, fast response, low cost and 
portability have gained increased attention in recent years [16-19].  In particular, use of electrochemical impedance 
spectroscopy (EIS) coupled with SAMs is very promising to result in label free biosensing of cortisol as they allow 
the recording of direct binding event occurring at the electrode surfaces through changes in capacitance and 
resistance.  In addition, the data points are generated using a small perturbation in signal, which reduces the matrix 
interference [20]. 
This paper reports on accurate measurement of cortisol in ISF and saliva using antibody modified gold 
microelectrode arrays via DTSP-SAM. ISF was extracted using a novel method that allows continuous harvesting 
of ISF over 72 hours. EIS is used as a characterization tool and for cortisol estimation via recording of charge 
transfer processes occurring at the sensor-sample interface.  This research establishes the feasibility of using EIS 
based biosensor for a rapid disposable cortisol detector. 
2. Materials and methods 
2.1. Chemicals and reagents 
Dithiobis(succinimidyl propionate) (DTSP) and sodium borohydride (NaBH4) were purchased from 
ThermoFisher Scientific.  Monoclonal cortisol antibody (anti-cortisol, C-Mab) 2330-4809 was procured from Abd 
Serotec.  Phosphate buffered saline (PBS) tablets and hydrocortisone (cortisol) were purchased from Sigma Aldrich. 
All other chemicals were of analytical grade and were used without further purification.  Working solutions of 
hydrocortisone were prepared by dilution in PBS (10 mM, pH 7.4).  Saliva and ISF samples were collected to mimic 
a 24-hour circadian rhythm and were provided by Guided Therapeutics Inc.  The results of Electrochemical 
Impedance Spectroscopy (EIS) measurements were correlated with ELISA measurements of duplicate samples of 
saliva and ISF, which was performed by the Systems Laboratory of Dr. Clemens Kirschbaum in Dresden, Germany. 
2.2. Measurement and apparatus 
EIS was utilized to characterize the bio-electrode fabrication and to estimate cortisol as a function of its 
concentration.  EIS measurements were carried out at equilibrium potential without external biasing in the frequency 
range of 0.1–105 Hz with a 5 mV amplitude using Autolab Potentiostat/Galvanostat (Eco Chemie, Netherlands).  
EIS measurements were carried out using 30 μl of PBS solution (10 mM, pH 7.4) containing mixture of 5mM 
Ferrocyanide and 5mM Ferricyanide i.e. 5 mM  4/3
6)(CNFe as a redox probe.  Nyquist plots of impedance spectra in 
present studies have been exploited to study charge transfer change at sensor-solution interfaces after DTSP SAM 
formation, C-Mab binding and ethanol amine blocking, the change of charge resistance with changing concentration 
of cortisol and to measure association constant for the cortisol–C-Mab interaction.  All EIS spectra were recorded in 
PBS containing 5 mM  4/3
6)(CNFe as a redox probe.   
2.3. Fabrication of test chip, SAM Preparation and Antibody Immobilization 
The biosensor chips were fabricated on oxidized silicon wafer using standard photolithography techniques [15].  
Briefly, Cr/Au and Cr/Ag layers deposited using evaporation and were patterned, through lift off.  Gold 
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microelectrode arrays with 5μm wide electrode fingers at a pitch of 15 μm were used.  As a final step, SU8 chamber 
patterned around the electrodes using SU8 50 to create a sample well around these electrodes (Figure 1). 
Figure 1:  Schematic of EA/C-Mab/DTSP/Au bio-electrode fabrication. 
The gold microelectrode array chips were pre-cleaned with acetone, isopropyl alcohol, and de-ionized water.  Next 
they were exposed to pre-reduced 2mg/ml solution of DTSP in acetone for SAM formation.  The DTSP SAM 
modified electrodes were then rinsed with acetone to remove any unbound DTSP followed by water rinsing.  
Cortisol antibodies were covalently attached to DTSP-SAM by incubating the electrode in antibody (C-Mab) 
solution.  Cortisol antibodies were covalently attached to DTSP self-assembled monolayer by incubating the 
electrode in 30 μl of 1 μg/ml antibody in phosphate buffer saline (PBS) solution (10 mM, pH 7.4), for 1 hr. Covalent 
binding results from the facile reaction between amino group of C-Mab and reactive succinimidyl group of the 
DTSP on the SAM surface.  The sensor (C-Mab/DTSP/Au) was washed thoroughly with PBS to remove any 
unbound biomolecules. Blocking of unreacted succinimidyl group on DTSP SAM and to remove extra unbound 
antibodies onto the electrode surface was achieved using ethanol amine.  Figure 1 schematically illustrates  EA/C-
Mab/DTSP/Au bio-electrode fabrication. The fabricated bio-electrodes were characterized using the electrochemical 
impedance technique. 
3. Results and discussion 
3.1. EIS studies 
Figure 2: ȋȌEIS spectra of 
EA/C-Mab/DTSP/Au for 
cortisol concentration (i) 
buffer, (ii) 1 pM, (iii) 10 
pM, (iv) 100 pM, (v) 1nM, 
(vi) 10nM and (vii) 100 nM 
(viii) 1 μMǡ ȋȌ Linearity 
curve for normalized data 
obtained from EIS studies 
for d 
Ǥ

Figure 2a shows the 
EIS spectra obtained on 
the EA/C-Mab/DTSP/Au bio-electrode for cortisol concentrations 1 pM–1 μM.  For each concentration, EIS spectra 
was recorded in PBS containing 5 mM  4/3
6)(CNFe after 30 min incubation of bio-electrode in desired concentration 
of cortisol followed by PBS washing. Figure reveals that increasing cortisol concentration result in increase of 
diameter in Nyquist plots, indicating the successful interaction of cortisol with immobilized C-Mab on bio-
electrode.  The increase in diameter can be attributed to the decrease of electron transfer for redox probe due to 
resulting insulating layer of cortisol on bioelectrode surface.  A linear relationship between the change in Rct 
values and the logarithm of cortisol concentrations was observed for the cortisol concentrations in the range of 1 
pM–1μM.  This biosensing electrode reveals the sensitivity of 1.165 kȍ/M with standard deviation of 0.423 kȍ
and correlation coefficient of 0.988.  However, to account for the variation in initial impedance values for 
individual bio- electrode and to confirms that observed change in impedance was due to surface modification 
occurring by cortisol binding and not due to superimposed effects, all experiments were carried out using a step-by-
step approach to increasing cortisol concentration and all Rct data set was normalized to [Rct for desired 
concentration / Rct of blank bio-electrode].  Figure 2b, shows curve for normalized data and reveals the linear 
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Time of 
sampling 
AND Subject 
Sample Rct  (100xdil 
ISF) 
sample/base 
(A) 
ISF Cortisol Value 
after normalization 
((Ax10)/0.65) (nM) 
[Elisa value] 
Rct  (100xdil 
Saliva) 
sample/base 
(B) 
Saliva Cortisol 
Value after 
normalization 
(B/0.18)(nM) 
[Elisa value] 
8AM-2PM 
Sub 2,4,6 
Sub2 2.16 33.23 [32.19] 2.32 12.89 [12.23] 
Sub 4 2.55 39.23 [40.38] 1.78 9.89 [10.75] 
Sub 6 1.85 28.46 [28.37] 1.8 10.0 [10.3] 
2PM-8PM 
Sub 2,4,6 
Sub 9 1.82 28.0 [26.35] 2.52 14.0 [4.87] 
Sub 11 2.29 35.23 [36.43] 1.69 9.39 [7.95] 
Sub 13 1.97 30.31 [26.55] 1.39 7.72 [4.01] 
8AM-2PM 
Sub 1,3,5 
Sub 1 2.53 38.92 [39.64] 1.74 9.67 [9.06] 
Sub 3 2.95 45.38 [49.41] 2.37 13.17 [13.95] 
Sub 5 2.27 34.92 [30.0] 1.56 8.67 [7.67] 
2PM-8PM 
Sub 1,3,5 
Sub 8 2.67 41.08 [-] 1.56 8.67 [6.21] 
Sub 10 2.88 44.31 [-] 1.96 10.89 [11.0] 
Sub 12 1.60 24.61 [24.94] 1.52 8.44 [4.3] 
range of 1 pM–1μM.  It exhibit correlation coefficient of 0.986 and standard deviation of 1.23. Fig 2b reveals that 
after normalization all electrodes shows similar response within the error of 4% (shown as error bars) 
3.2. Selectivity studies and In-vitro saliva and ISF studies 
For selectivity studies bio-electrode was investigated in relation to corticosterone (data not shown).  It was found 
that the change in Rct for corticosterone was negligible as compared to cortisol with same concentration and can be 
attributed to the 10% affinity of used C-Mab for corticosterone.  Thus, the bio-electrode is quite selective and can be 
used for selective estimation of cortisol.  For in-vitro studies, bioelectrode was successfully used for in-vitro 
measurement of cortisol levels in saliva and ISF and results were compared with the ELISA results.  From table1 it 
is clear that values obtained using our system and with commercial ELISA projected a similar trend.  It was 
observed that the EIS cortisol values can be used to get the local cortisol concentrations if normalized with a factor 
of 10/0.65 for ISF and 1/0.18 for saliva (Table 1). 
Table 1: Estimation of cortisol 
concentration in real ISF and saliva 
samples. 
Conclusions: 
Dithiobis(succinimidyl 
propionate) (DTSP) self-assembled 
monolayer (SAM) functionalized gold 
microelectrode array can be used to 
fabricate an ultrasensitive 
impedemetric cortisol immunosensor. 
Covalently immobilized monoclonal 
cortisol antibody based EA/C-
Mab/DTSP/Au electrode exhibits 
linear behaviour in the concentration 
range 1 pM–1μM, has low detection limit of 1 pM with high linear regression coefficient of 0.986. The bio-
electrode was found selective against corticosterone. In addition, results show the possibility to verify the expected 
circadian rhythm both within saliva and ISF samples. This sensor, when used as part of a device, can allow a 
continuous readout of cortisol levels in the ambulatory setting, provide 24-hour diurnal data for the first time by 
allowing us to get the night time minimum value and can identify precise point in sleep cycle at which cortisol 
levels in the body begins its morning cycle. 
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